Home › Peptides

What Is Compounded Semaglutide?

By the Strength from the Well Editorial Team · Evidence last reviewed September 2026 · Not reviewed by a licensed clinician (why we say that)

The short answer

Compounded semaglutide is a version of the drug prepared by a compounding pharmacy rather than manufactured and packaged by the company that holds the FDA approval. Compounded drugs are not reviewed or approved by the FDA for safety, effectiveness, or quality, and federal law only allows a pharmacy to compound a copy of an approved drug in limited circumstances, most notably while that drug is in official shortage. When the FDA declared the semaglutide and tirzepatide shortages resolved, that legal basis largely went away, and the rules in this area have continued to shift, so check the FDA's current guidance rather than relying on any article.

Key points

Compounding is a legitimate, longstanding pharmacy practice for individualized medicines, not an inherently shady one.
Compounded drugs are not FDA-approved. The agency does not verify their strength, purity, or consistency before they are sold.
Copying a commercially available approved drug is generally not permitted; the shortage exception is what opened the door.
The FDA declared the tirzepatide shortage resolved in late 2024 and the semaglutide shortage resolved in early 2025, with wind-down deadlines for compounders in 2025.
Salt forms such as semaglutide sodium or semaglutide acetate are not the same active ingredient as the approved drug.
Dosing errors have been a documented, serious problem with products that require the user to measure their own dose.

What compounding actually is

Compounding is the practice of a licensed pharmacist preparing a medication tailored to an individual patient. It has existed longer than the modern pharmaceutical industry and it solves real problems: a child who needs a liquid version of a drug that only comes as a tablet, a patient allergic to a dye in the commercial product, a strength that is not manufactured.

There are two main categories in US law. A traditional compounding pharmacy prepares medications for identified individual patients with prescriptions. An outsourcing facility can produce larger batches without patient-specific prescriptions and is subject to stricter federal manufacturing requirements and FDA inspection.

Both categories differ from an approved drug manufacturer in one decisive way. The FDA does not review compounded drugs before they reach patients. There is no agency verification that the product contains what it says, in the amount it says, made consistently from batch to batch. Regulators inspect facilities and act when problems surface, but the pre-market review that stands behind an approved drug is simply not part of the picture.

Why compounded GLP-1 products appeared

Federal law generally prohibits compounding a copy of a commercially available approved drug. That rule exists to keep the approval system from being routed around.

There is an exception: when a drug appears on the FDA's official shortage list, compounders may prepare versions of it. When demand for semaglutide and tirzepatide outran supply, both landed on that list, and an entire industry formed almost overnight. Telehealth companies, clinics, and med spas began offering compounded versions, often at a fraction of the branded price, and for a period this was a lawful response to a genuine shortage.

It also became something else. Some sellers built permanent businesses on a temporary exception. Products appeared with added ingredients such as vitamins, sold in vials requiring the patient to draw up their own dose, priced and marketed like a consumer subscription rather than a prescription medication.

What changed when the shortages ended

The FDA has since declared both the tirzepatide and semaglutide shortages resolved and set wind-down deadlines after which compounders were no longer to produce copies of these drugs. The exact dates and the enforcement position have moved more than once and have been litigated, so treat any specific date you read anywhere, including here, as something to confirm against the FDA's current guidance. Litigation followed, and the agency's positions and the deadlines were the subject of ongoing dispute.

The practical meaning for a patient is this: the legal footing that allowed mass-market compounded semaglutide was tied to the shortage, and the shortage was declared over. Anyone still selling a compounded copy is either operating under a narrow individualized exception, such as a documented clinical need for a formulation the approved product cannot provide, or is operating outside the rules.

This area has kept moving. Rather than trusting the date on any article, including this one, check the FDA's current guidance on compounding and on drug shortages before making a decision, and ask the pharmacy directly what legal basis it is compounding under.

The specific safety concerns

These are not hypothetical, and they are worth knowing in detail.

Salt forms. Some products were sold containing semaglutide sodium or semaglutide acetate. The FDA has stated that these salt forms are different active ingredients from the semaglutide base in the approved products, and that their safety and effectiveness have not been established. A product containing one of them is not a version of the approved drug in any meaningful sense.

Dosing errors. The approved products come in devices that deliver a set dose. Many compounded products come as a vial and a syringe, and the patient measures the dose. Poison control centers and the FDA have reported cases of people taking many times the intended amount, sometimes because instructions were written in one unit and the syringe was marked in another. Overdoses have produced severe nausea and vomiting, dehydration, low blood sugar, and hospital admissions.

Unverified content. Without pre-market review, the amount of active ingredient in a compounded vial rests on the pharmacy's own practices. Quality among compounding pharmacies varies enormously, and the patient has no way to tell a rigorous operation from a careless one by looking at the package.

Ingredients that were never studied together. Combination products that add other substances to semaglutide have not been tested as combinations in anyone. The fact that each ingredient is familiar does not mean the mixture has been evaluated.

Counterfeits. Separately from compounding, counterfeit versions of branded pens have been found in the legitimate supply chain in some countries, which is part of why buying from a verifiable licensed pharmacy matters even for the branded product.

Questions to ask if a compounded version is offered to you

If a clinician or service offers you a compounded GLP-1, these questions are fair, and the answers are informative even when they are evasive.

What is the name and state license number of the pharmacy preparing it, and is it a 503A pharmacy or a 503B outsourcing facility?
What exact active ingredient is in it, and is it the base form rather than a salt form?
What is the legal basis for compounding a copy of an approved drug right now?
Is this a patient-specific prescription based on a clinical reason I cannot use the approved product?
Who performs potency and sterility testing, and can I see results for my batch?
How is the dose measured, in what units, and who will teach me to draw it correctly?
Who do I call if I have a reaction at 2 a.m., and will this be documented to my regular doctor?

Why people take this route anyway

It would be dishonest to write about compounded semaglutide as though people choose it out of carelessness. Most choose it because the approved product costs more per month than they can absorb, their insurance excludes it, and they have watched their health decline while being told the treatment exists but not for them.

That is a real bind and it deserves to be named rather than lectured at. What is worth understanding is that the compounded route trades a financial problem for an information problem. You save money and you give up the ability to know what you are injecting. For some people, with a licensed prescriber, careful sourcing, and clear-eyed acceptance of that trade, it may still be the choice they make. For others, the trade looks different once it is stated plainly.

Before settling for that trade, work the legitimate routes hard: the manufacturer's patient assistance program if you have no drug coverage, the manufacturer's direct self-pay pricing, a formal appeal if you have insurance that denied you, and a frank conversation with a prescriber about older or cheaper medications. Those paths are tedious and slow. They are also the ones where somebody is accountable for what is in the vial.

You only get one body, and the point of taking care of it is not to win an argument about medications. It is to still be here, functioning, for the people who need you. Both impatience and paralysis can cost you that. A steady, informed decision usually beats either.

Common questions

Is compounded semaglutide the same as Ozempic or Wegovy?

No. It is not made by the approval holder, not reviewed by the FDA, and not guaranteed to contain the same active ingredient in the same amount. Some compounded products have contained salt forms that the FDA has said are different active ingredients entirely.

Is compounded semaglutide legal?

Compounding itself is legal, but copying a commercially available approved drug generally is not, outside limited exceptions such as an official shortage or a documented individual clinical need. The FDA has declared the semaglutide and tirzepatide shortages resolved, which removed the main basis for mass-market compounded copies. This area has been actively litigated, so check current FDA guidance.

Why is compounded semaglutide so much cheaper?

It skips the costs of clinical development, FDA review, and branded distribution, and it is priced competitively in a market with many sellers. The savings come partly from efficiency and partly from the absence of the oversight that makes an approved product what it is.

How can I tell if a compounding pharmacy is legitimate?

Ask for the pharmacy's name, state license, and whether it is registered with the FDA as an outsourcing facility, then verify the license with the state board of pharmacy directly. Legitimate pharmacies answer these questions readily. Sellers that will not name the pharmacy, require no real prescription, or take payment only by cryptocurrency or cash apps are telling you what you need to know.

What should I do if I have been using a compounded version?

Do not make the decision alone or abruptly on the basis of an article. Bring the actual vial and label to a clinician, tell them exactly what you have been taking and how you have been measuring it, and decide together what comes next. If you have symptoms that worry you, especially severe or persistent vomiting, dehydration, or severe abdominal pain, seek care promptly.

Sources

This is information, not medical advice. Strength from the Well is an independent publisher. Nothing here is a diagnosis, a prescription, or a recommendation to start or stop any treatment. Talk to a clinician who knows your history before you act on anything you read here — including anything you read here that contradicts them.